BioNTech SE
BioNTech SE (BNTX) Stock Overview
Explore BioNTech SE’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
27.7B
P/E Ratio
-30.54
EPS (TTM)
$-3.75
ROE
-0.04%
BNTX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BioNTech SE (BNTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $96.47.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -30.54 and a market capitalization of 27.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.